Gene · 2931
Papers2,889
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,889
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Virtual screening for small-molecule pathway regulators by image-profile matching. | Cell Syst | 2022 | 36057257 | PubTator, text mining | PubMed |
| Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart. | Circ Res | 2022 | 36052698 | PubTator, text mining | PubMed |
| Impact of a bisphenol A, F, and S mixture and maternal care on the brain transcriptome of rat dams and pups. | Neurotoxicology | 2022 | 36041667 | PubTator, text mining | PubMed |
| Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder. | Transl Psychiatry | 2022 | 36038539 | PubTator, text mining | PubMed |
| Exercise-induced signaling pathways to counteracting cardiac apoptotic processes. | Front Cell Dev Biol | 2022 | 36036015 | PubTator, text mining | PubMed |
| Deletion of Macrophage-Specific Glycogen Synthase Kinase (GSK)-3α Promotes Atherosclerotic Regression in Ldlr-/- Mice. | Int J Mol Sci | 2022 | 36012557 | PubTator, text mining | PubMed |
| Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells. | Int J Mol Sci | 2022 | 36012403 | PubTator, text mining | PubMed |
| Protein Phosphorylation in Cancer: Unraveling the Signaling Pathways. | Biomolecules | 2022 | 36008930 | PubTator, text mining | PubMed |
| Unraveling the multi-targeted curative potential of bioactive molecules against cervical cancer through integrated omics and systems pharmacology approach. | Sci Rep | 2022 | 35989375 | PubTator, text mining | PubMed |
| Involvement of the Wnt pathway in BVDV cytopathogenic strain replication in primary bovine cells. | Virol J | 2022 | 35986298 | PubTator, text mining | PubMed |
| Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. | Cancer Cell Int | 2022 | 35971151 | PubTator, text mining | PubMed |
| Placental growth factor stabilizes VEGF receptor-2 protein in retinal pigment epithelial cells by downregulating glycogen synthase kinase 3 activity. | J Biol Chem | 2022 | 35970387 | PubTator, text mining | PubMed |
| Differential roles and regulation of the protein kinases PAK4, PAK5 and PAK6 in melanoma cells. | Biochem J | 2022 | 35969127 | PubTator, text mining | PubMed |
| Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19. | Int J Mol Sci | 2022 | 35955801 | PubTator, text mining | PubMed |
| Wound Healing Impairment in Type 2 Diabetes Model of Leptin-Deficient Mice-A Mechanistic Systematic Review. | Int J Mol Sci | 2022 | 35955751 | PubTator, text mining | PubMed |
| Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer. | Cancers (Basel) | 2022 | 35954375 | PubTator, text mining | PubMed |
| Assessing Bioavailability and Bioactivity of 4-Hydroxythiazolidine-2-Thiones, Newly Discovered Glucosinolate Degradation Products Formed During Domestic Boiling of Cabbage. | Front Nutr | 2022 | 35938125 | PubTator, text mining | PubMed |
| A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma. | Front Oncol | 2022 | 35936719 | PubTator, text mining | PubMed |
| Prevention and treatment of natural products from Traditional Chinese Medicine in depression: Potential targets and mechanisms of action. | Front Aging Neurosci | 2022 | 35923544 | PubTator, text mining | PubMed |
| MAP3K4 promotes fetal and placental growth by controlling the receptor tyrosine kinases IGF1R/IR and Akt signaling pathway. | J Biol Chem | 2022 | 35921893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2931/papers?page=19